Ascent Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$243K Sell
746
-3
-0.4% -$978 0.01% 634
2025
Q1
$202K Buy
+749
New +$202K 0.01% 665